India Outperforms with High Growth and Low Volatility

India Outperforms with High Growth and Low Volatility

Morgan Stanley’s Chief Asia Equity Strategist Jonathan Garner explains why Indian equities are our most preferred market in Asia.


Read more insights from Morgan Stanley.


----- Transcript -----


Welcome to Thoughts on the Market. I’m Jonathan Garner, Morgan Stanley’s Chief Asia Equity Strategist. Today I’ll discuss why we remain positive on India’s long-term equity story.

It’s Tuesday, the 24th of June at 9am in Singapore.

We’ve had a long-standing bullish outlook on the India economy and its stock market. In the last five years MSCI India has delivered a total return in U.S. dollars of 145 percent versus 94 percent for global equities and just 39 percent for emerging markets. Indian equities are our most preferred market within Asia for three key reasons. First, India’s superior economic and earnings growth. Second, lower exposure to trade tariffs. And third, a strong domestic investor base. And all of this adds up to structural outperformance not just in Asia but indeed globally, and with significantly lower volatility than peer group markets.

So let’s dive deeper. To start with – the macroeconomic backdrop. We expect India to account for 20 percent of overall incremental global GDP growth in the coming decade. Manufacturing competitiveness is improving thanks to bolstered infrastructure in power, ports, roads, freight transport systems as well as investments in social infrastructure such as water, sewage and hospitals.

Additionally, India's growing middle class offers market opportunities to companies across many product categories. There’s robust domestic consumption, a strong investment cycle led by public and private capital expenditure and continuing structural reforms, including in the legal sphere. GDP growth in the first quarter was more than 7 percent and our team expects over 6 percent in the medium term, which would be by far the highest of the major economies.

Furthermore, we continue to expect robust corporate earnings growth. Since the end of COVID, MSCI India has delivered around 12 percent per annum [U.S.] dollar earnings per share growth versus low single digits for Emerging Markets overall. And we forecast 14 percent and 16 percent over the next two fiscal years. Growth drivers in the short term include an emerging private CapEx cycle, re-leveraging of corporate balance sheets, and a structural rise in discretionary consumption – signaling increased business and consumer confidence, after last year’s elections.

Another key reason that we’re positive on India currently is its lower-than-average vulnerability to ongoing trade and tariff disputes between the U.S. and its trade partners. Exports of goods to the U.S. amount to only 2 percent of India’s GDP versus, for example, 10 percent in Thailand or 14 percent in Taiwan. And India’s total goods exports are only around 12 percent of GDP. Moreover, for the time being, India’s very large services sector’s exports are not exposed to tariff actions, and are actually early beneficiaries of AI adoption.

Finally, India’s strong individual stock ownership means that there’s persistent retail buying, which underpins the equity market. Systematic Investment Plan (SIP) flows driven by a young urbanizing population are making new highs, and in May amounted to over U.S.$3 billion. They provide consistent capital inflows. That means that this domestic bid on stocks is unlikely to fade anytime soon.

This provides a strong foundation for the market and supports valuations which are slightly above emerging market averages. It also means that its market beta to global equities are low and falling, approximately 0.4 versus 1.1 ten years ago. And price volatility is well below other emerging markets. All told, making India an attractive play in volatile times.

Thanks for listening. If you enjoy the show, please leave us a review wherever you listen and share Thoughts on the Market with a friend or colleague today.

Avsnitt(1575)

Quantitative Strategies: A 2023 Return?

Quantitative Strategies: A 2023 Return?

In 2022 it seemed like there was nowhere to hide from the negative returns in traditional investing. But if we look to quantitative strategies, we may find more flexibility for the year ahead.----- Tr...

11 Jan 20239min

Mike Wilson: Challenging the Consensus on 2023

Mike Wilson: Challenging the Consensus on 2023

As 2023 begins, most market participants agree the first half of the year could be challenging. But when we dig into the details, that's where the agreement ends.----- Transcript -----Welcome to Thoug...

10 Jan 20234min

Martijn Rats: The 2023 Global Oil Outlook

Martijn Rats: The 2023 Global Oil Outlook

With an eventful year for the oil market behind us, what are the factors that might influence the supply, demand, and ultimately the pricing of oil and gas in 2023?----- Transcript -----Welcome to Tho...

9 Jan 20234min

Andrew Sheets: Lessons from Last Year

Andrew Sheets: Lessons from Last Year

Discover what 2022, a historic year for markets, can teach investors as they navigate the new year.----- Transcript -----Welcome to Thoughts on the Market. I'm Andrew Sheets, Chief Cross Asset Strateg...

6 Jan 20233min

Chetan Ahya: Has Inflation in Asia Peaked?

Chetan Ahya: Has Inflation in Asia Peaked?

With the fight against inflation quieting down in many regions, Asia saw a relatively small step up in inflation. Will that leave 2023 open to the possibility of growth outperformance?----- Transcript...

5 Jan 20233min

Michael Zezas: Gridlock in the House of Representatives

Michael Zezas: Gridlock in the House of Representatives

The House of Representatives continues its struggle to appoint a new Republican Speaker. What should investors consider as this discord sets the legislative tone for the year?----- Transcript -----Wel...

4 Jan 20233min

Terence Flynn: The Next Blockbuster for Pharma?

Terence Flynn: The Next Blockbuster for Pharma?

As new weight management medications are being developed, might the obesity market parallel the likes of hypertension or high blood pressure to become the next blockbuster Pharma category?----- Transc...

3 Jan 20233min

End-of-Year Encore: 2023 Global Macro Outlook - A Different Kind of Year

End-of-Year Encore: 2023 Global Macro Outlook - A Different Kind of Year

Original Release on November 15th, 2022: As we look ahead to 2023, we see a divergence away from the trends of 2022 in key areas across growth, inflation, and central bank policy. Chief Cross Asset St...

30 Dec 202211min

Populärt inom Business & ekonomi

badfluence
framgangspodden
varvet
rss-svart-marknad
rss-jossan-nina
uppgang-och-fall
svd-tech-brief
avanzapodden
dynastin
rss-borsens-finest
borsmorgon
rss-kort-lang-analyspodden-fran-di
rss-dagen-med-di
rss-inga-dumma-fragor-om-pengar
24fragor
bathina-en-podcast
lastbilspodden
tabberaset
montrosepodden
ekonomiekot-extra